BioCatalystWatch
ACIUWorkspace / ACIU / OverviewCompany library
Price
Market cap
Next catalystExpected 2H 2026ACI-7104 · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

ACI-7104

Vaccine

Pathological α-synuclein

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ACI-19764

Small molecule

NLRP3

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ACI-7104

Vaccine

Pathological α-synuclein

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ACI-19764

Small molecule

NLRP3

Upcoming / outlook

  • Timing and evidence

Other pipelines

ACI-19764

Small molecule

NLRP3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Morphomer a-syn

Small molecule

Intracellular α-synuclein aggregates

PreINDP1P2P3FilingApproved
Upcoming / outlook

ACI-12589

α-synuclein

PreINDP1P2P3FilingApproved
ACI-19626

Aggregated TDP-43

PreINDP1P2P3FilingApproved
ACI-19626

Aggregated TDP-43

TDP-43 immunotherapy

TDP-43

PreINDP1P2P3FilingApproved

Partner / License out

Vaccine

Toxic Aβ

Radiopharmaceutical

Tau deposits

Radiopharmaceutical

Tau deposits

History / paused

Vaccine

Phosphorylated Tau (pTau) × Non-phosphorylated Tau

PreINDP1P2P3FilingApproved

Small molecule

Aggregated Tau × 3R/4R Tau

PreINDP1P2P3FilingApproved

Vaccine

Phosphorylated Tau (pTau)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status
1M

Market Reaction / Supply Context

Market Structure

ACIU PR & News

PR & News

ACIU SEC archive